Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Surgalign Holdings Inc SRGAQ

Healthcare Medical Instruments & Supplies
Surgalign Holdings, Inc. is a medical technology company. The Company is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology... see more

Recent & Breaking News (PINL:SRGAQ)

RTI Biologics Schedules 2013 First Quarter Earnings and Conference Call for April 25, 2013

Business Wire April 18, 2013

RTI Biologics Announces Positive Clinical Results for BioCleanse®-Processed BTB Allografts Used in ACL Reconstruction

Business Wire March 20, 2013

RTI Biologics® Receives 510(k) Clearance for Porcine Dermis Implant

Business Wire March 13, 2013

RTI Biologics Launches New Line of Biologic Implants at Americas Hernia Society's 15th Annual Hernia Repair Conference, March 13-16

Business Wire March 12, 2013

RTI Biologics Announces 2012 Fourth Quarter, Full Year Results, 2013 Financial Guidance

Business Wire February 7, 2013

RTI Biologics Schedules 2012 Fourth Quarter, Year End Earnings and Conference Call for February 7, 2013

Business Wire January 31, 2013

RTI Biologics Breaks Ground on New Facility in Alachua, Fla.

Business Wire January 7, 2013